APA (7th ed.) Citation

Broos, J. Y., van der Burgt, R. T. M., Konings, J., Rijnsburger, M., Werz, O., de Vries, H. E., . . . Kooij, G. (2024). Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: Fueling or dampening disease progression? Journal of Neuroinflammation, 21(1), 1. https://doi.org/10.1186/s12974-023-02981-w

Chicago Style (17th ed.) Citation

Broos, Jelle Y., Rianne T. M. van der Burgt, Julia Konings, Merel Rijnsburger, Oliver Werz, Helga E. de Vries, Martin Giera, and Gijs Kooij. "Arachidonic Acid-derived Lipid Mediators in Multiple Sclerosis Pathogenesis: Fueling or Dampening Disease Progression?" Journal of Neuroinflammation 21, no. 1 (2024): 1. https://doi.org/10.1186/s12974-023-02981-w.

MLA (9th ed.) Citation

Broos, Jelle Y., et al. "Arachidonic Acid-derived Lipid Mediators in Multiple Sclerosis Pathogenesis: Fueling or Dampening Disease Progression?" Journal of Neuroinflammation, vol. 21, no. 1, 2024, p. 1, https://doi.org/10.1186/s12974-023-02981-w.